This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Biotech Pharmaceutical Co. Ltd., Centro De Inmunologia Molecular. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Zhi Bai - Innovator in Antibody Production
Introduction
Zhi Bai is a notable inventor based in Province, China. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant antibodies. His innovative methods have the potential to enhance the efficiency of antibody production processes.
Latest Patents
Zhi Bai holds a patent for a method titled "Method for obtaining high-yield, stable expression cell clones and antibody molecules obtained thereby." This patent describes a process for obtaining high-yield, stable expression cell clones from myeloma cell lines in a protein-free culture medium. The method is designed for industrial production of recombinant antibodies and consists of three stages: adapting to a protein-free culture medium, culturing cells at low density, and screening high-yield cell clones. This innovative approach allows for the production of a humanized anti-NeuGcGM3 14F7 recombinant antibody.
Career Highlights
Throughout his career, Zhi Bai has worked with various organizations, including Biotech Pharmaceutical Co. Ltd. and Centro De Inmunologia Molecular. His experience in these companies has contributed to his expertise in the field of biotechnology and antibody production.
Collaborations
Zhi Bai has collaborated with notable professionals in the industry, including MeyLen Chea and Julio Palacios. These collaborations have further enriched his work and expanded his impact in the field.
Conclusion
Zhi Bai's innovative methods in antibody production demonstrate his commitment to advancing biotechnology. His contributions are paving the way for more efficient and effective production processes in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile